Literature DB >> 27325944

Does syncope require rhythmic and non-rhythmic evaluation in patients with previous MI?

B Brembilla-Perrot1, C Suty-Selton1, F Alla2, P Y Zinzius1, H Blangy1, B Azman1, A Terrier de la Chaise1, P Louis1, L Groben1, K Djaballah1, O Selton1, S Magalhaes1, L Muresan1, J Cedano1, A Abdelaal1, N Sadoul1.   

Abstract

BACKGROUND: Multiple factors, in addition to left ventricular ejection fraction (LVEF) influence the risk of mortality in coronary artery disease. The purpose of this study was to evaluate the main causes of syncope after myocardial infarction (MI) and to propose an algorithm of management.
METHODS: 356 patients consecutively admitted for syncope and history of MI (>1 month), without ventricular tachycardia (VT), underwent echocardiography, Holter monitoring, head-up tilt test, exercise testing, signal-averaged ECG, electrophysiological study (EPS) and evaluation of coronary status. The mean follow-up was 4±2 years.
RESULTS: Monomorphic VT, ventricular flutter or fibrillation (VF) and supraventricular tachyarrhythmia were respectively induced at EPS in 87, 63 and 39 patients; conduction disturbances were noted in 23 patients, and 57 patients had several abnormalities. Among the 144 patients with negative EPS, coronary ischaemia was identified in 37 patients, and hypervagotonia in 27 patients. All studies remain negative in 84 patients (23.6%), more frequently women (p<0.001). Four patients died suddenly during follow-up. A longer QRS duration, a lower LVEF and grade IVa,b of Lown on Holter ECG were associated with the induction of VT. LVEF<40% and VT/VF induction were predictors of cardiac mortality, VT was a predictor of sudden death, and low LVEF and advanced age were predictors of death by heart failure.
CONCLUSION: Myocardial ischaemia, hypervagotonia, conduction abnormalities, ventricular or supraventricular tachyarrhythmias were identified in 76% of patients with syncope after MI. Several factors of syncope were found in 57 patients (16%). Non-invasive rhythmological and systematic coronary status assessment should be recommended in patients with syncope following MI.

Entities:  

Keywords:  Syncope; electrophysiological study; management; myocardial infarction; prognosis

Year:  2010        PMID: 27325944      PMCID: PMC4898518          DOI: 10.1136/ha.2009.001602

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  26 in total

Review 1.  Current evaluation and management of syncope.

Authors:  Wishwa N Kapoor
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

2.  Incidence and mechanism of presyncope and/or syncope associated with paroxysmal junctional tachycardia.

Authors:  B Brembilla-Perrot; D Beurrier; P Houriez; O Claudon; J Wertheimer
Journal:  Am J Cardiol       Date:  2001-07-15       Impact factor: 2.778

3.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

4.  Association of myocardial ischemia with mortality and implantable cardioverter-defibrillator therapy in patients with coronary artery disease at risk of arrhythmic death.

Authors:  Abdou Elhendy; Scott Chapman; Thomas R Porter; John Windle
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

5.  Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome.

Authors:  J Brugada; L Aguinaga; L Mont; A Betriu; J Mulet; G Sanz
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

6.  Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator.

Authors:  Arash Arya; Majid Haghjoo; Mohammad Reza Dehghani; Amir Farjam Fazelifar; Mohammad-Hosein Nikoo; Ataollah Bagherzadeh; Mohammad Ali Sadr-Ameli
Journal:  Am J Cardiol       Date:  2006-02-01       Impact factor: 2.778

7.  Use of implantable loop recorders in the diagnosis and management of syncope.

Authors:  D J Farwell; N Freemantle; A N Sulke
Journal:  Eur Heart J       Date:  2004-07       Impact factor: 29.983

8.  [Risk factors for cardiac mortality in cases of syncope with previous history of myocardial infarction].

Authors:  B Brembilla-Perrot; C Suty-Selton; F Alla; D Beurrier; P Houriez; O Claudon; A Terrier de la Chaise; P Louis; N Sadoul; M Andronache; H Miltjoen; Y Juillière
Journal:  Arch Mal Coeur Vaiss       Date:  2003-12

9.  Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.

Authors:  Alfred E Buxton; Kerry L Lee; Gail E Hafley; Luis A Pires; John D Fisher; Michael R Gold; Mark E Josephson; Michael H Lehmann; Eric N Prystowsky
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.